Your session is about to expire
← Back to Search
MODERNA SARS-CoV-2 Vaccine for Chronic Kidney Disease (BOOST KIDNEY Trial)
BOOST KIDNEY Trial Summary
This trial is being done to see if MODERNA or Pfizer-BioNTech COVID-19 vaccine is better in boosting immunity in chronic kidney disease and dialysis patients.
- Chronic Kidney Disease
- COVID-19
- Coronavirus
BOOST KIDNEY Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.BOOST KIDNEY Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What other research has been done on the MODERNA SARS-CoV-2 Vaccine?
"As of today, there are a total of 56 active trials for the MODERNA SARS-CoV-2 Vaccine. Out of these, 19 are currently in Phase 3. Additionally, while several studies originate from Liverpool and New york, there are 1,317 total locations running trials for this vaccine globally."
Are we looking for more participants in this trial?
"The clinical trial in question is no longer recruiting patients, as indicated on the website clinicaltrials.gov. This page was originally created on September 30th, 2021 and last updated on August 5th, 2022. There are 1694 other trials that are currently enrolling participants."
How many people are currently signed up for this research project?
"Unfortunately, this particular trial is no longer admitting patients. The study was first made public on September 30th 2021 and the most recent update was on August 5th 2022. There are presently 1638 other studies that are still enrolling patients with covid-19 and 56 for the MODERNA SARS-CoV-2 Vaccine."
Have patients undergone this treatment before?
"There are currently 56 ongoing clinical studies for the MODERNA SARS-CoV-2 Vaccine across 332 cities and 38 countries. The first study began in 2020 and involved 120 patients. It completed its Phase 1 drug approval stage successfully. Since then, 27 other studies have been completed."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger